Pulse Biosciences
PLSE
44 hedge funds and large institutions have $4.38M invested in Pulse Biosciences in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 19 closing their positions.
957% more call options, than puts
Call options by funds: $148K | Put options by funds: $14K
5.99% less ownership
Funds ownership: 14.25% → 8.26% (-6%)
20% less funds holding
Funds holding: 55 → 44 (-11)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
78% less capital invested
Capital invested by funds: $19.9M → $4.38M (-$15.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$303K |
| 2 |
E
Ergoteles
New York
|
+$163K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$159K |
| 4 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$131K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.55M |
| 2 |
State Street
Boston,
Massachusetts
|
-$487K |
| 3 |
Renaissance Technologies
New York
|
-$378K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$301K |
| 5 |
Two Sigma Investments
New York
|
-$290K |
PLSE Hedge Fund Activity: Q2 2022 in Review
44 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2022, worth a combined $4.38M — down 78% from $19.9M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of PLSE and 10 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $303K. The largest seller was BlackRock, cutting an estimated $1.55M.
- 44 institutional investors held Pulse Biosciences (PLSE) as of Q2 2022, down from 55 in Q1 2022.
- Funds reported $4.38M of Pulse Biosciences stock for Q2 2022, down 78% quarter-over-quarter.
- 10 funds opened new Pulse Biosciences positions in Q2 2022 and 19 closed out, a net change of -9 holders.
- The largest Pulse Biosciences buyer in Q2 2022 was Millennium Management, an estimated $303K added.
- The largest Pulse Biosciences seller in Q2 2022 was BlackRock, an estimated $1.55M sold.
Based on aggregated 13F filings for Q2 2022.